Dr. Tania T Herrera, MD - Punta Pacifica Hospital John Hopkins affiliated - Maternal Fetal Medicine consultant

Dr. Tania T Herrera

MD

Punta Pacifica Hospital John Hopkins affiliated

Maternal Fetal Medicine consultant

Panama city, Panama | Panama

Main Specialties: Neonatal-Perinatal Medicine, Obstetrics & Gynecology

Additional Specialties: Obstetrics and Gynecology

ORCID logohttps://orcid.org/0000-0002-3603-1103


Top Author

Dr. Tania T Herrera, MD - Punta Pacifica Hospital John Hopkins affiliated - Maternal Fetal Medicine consultant

Dr. Tania T Herrera

MD

Introduction

I am a mother of twin girls and Maternal Fetal Medicine specialist working at Pacifica Salud Hospital affiliated to John Hopkins Medicine International. Since 2014 I have been working at Indicasat AIP and collaborating with different scientists Dr. Britton and Dr. Goodgridge at the Centers for Neuroscience and Center for Molecular Biology. That collaboration was fundamental in establishing our Research with Pregnant Patients.

Primary Affiliation: Punta Pacifica Hospital John Hopkins affiliated - Panama city, Panama , Panama

Specialties:

Additional Specialties:

Research Interests:


View Dr. Tania T Herrera’s Resume / CV

Education

Jan 2012
University of South Florida
Graduate in Clinical Research
USF Health
Mar 2002 - Feb 2004
Instituto Nacional de Perinatologia
Especialista en Medicina Materno Fetal
Mar 2002 - Mar 2003
Universidad Nacional Autónoma de Mexico (UNAM)
Diplomado en Medicina Basada en Evidencias
Jan 2002 - Jan 2003
Universidad Nacional Autónoma de México
Diplomado en Metodología de la investigación Clinica
Mar 2001 - Feb 2002
Universidad de Panama Facultad de Medicina
Diplomado en Genética Perinatal
Jan 1998 - Jan 2001
Complejo Hospitalario Dr Arnulfo Arias
Ginecología y Obstetricia
Ginecología Obstetricia
Jan 1989 - Jan 1995
Universidad de Panama
Doctor en Medicina
Facultad de Medicina

Experience

Oct 2017
National Investigator
Sistema Nacional de Investigación
Senacyt
Oct 2016 - Jan 2014
Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia
Associate Researcher
Aug 2004 - Apr 2010
Complejo Hospitalario Dr Arnulfo Arias
Medico Materno Fetal Secci´´on Ultrasonido
Ginecología Obstetricia
Aug 2004 - Nov 2006
Hospital Nacional
Especialista en Medicina Materno Fetal
Ginecología Obstetricia
Nov 2006 - Nov 2005
Hospital Punta Pacifica
Maternal Fetal Medicine Consultant
Ginecología Obstetricia
Aug 2001 - Dec 2001
Hospital Dr. Rafael Estévez Caja de Seguro Social
Jefe de Servicio de Ginecología y Obstetricia
Ginecología Obstetricia

Publications

3Publications

176Reads

91Profile Views

Blood-based biomarkers of adverse perinatal outcomes in maternal obesity.

J Matern Fetal Neonatal Med 2017 Dec 12;30(24):2991-2997. Epub 2017 Jan 12.

c Centro de Neurociencias y Unidad de Investigación Clínica , Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) , Clayton , Panamá.

Objective: Increasing maternal weight has been shown to predict adverse perinatal outcome, including increases in the relative risk of fetal death, stillbirth, neonatal death, perinatal death and infant death. In order to better understand the pathophysiological factors associated with obesity during pregnancy, the role of biomarkers associated with adverse outcomes in obese pregnant women is under investigation. The purpose of this review study was to examine potential biomarkers that could serve as effective screening strategies in obese pregnant women to reduce fetal and neonatal morbidity, as well as maternal morbidity.

Methods: Electronic databases (Pubmed, Embase) were searched for previously published research studies that investigated biomarkers associated with perinatal outcomes in obese pregnant women and the putative mechanisms underlying biomarker effects on pregnancy outcomes.

Results: It is evident that while several biomarkers predict perinatal complications in obese pregnant women, none fulfilled the criteria to be considered clinically useful.

Conclusion: There is a critical need for reliable blood-based biomarkers associated with an increased risk of adverse perinatal outcomes in obese pregnant women.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767058.2016.1271406DOI Listing
December 2017
164 Reads
1.500 Impact Factor

Ascertaining fetal Zika virus infection based on IgM antibody test in endemic settings.

Ultrasound Obstet Gynecol 2017 06;49(6):809

Centro de Neurociencias y Unidad de Investigación Clínica, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Ciudad Del Saber, Panama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/uog.17509DOI Listing
June 2017
3.853 Impact Factor

First trimester screening using ultrasound and serum markers in Panamanians: Factors associated with adverse pregnancy outcomes.

J Res Med Sci 2014 May;19(5):451-6

Center for Neuroscience and Clinical Research Unit, Institute for Scientific Research and Technological Services (INDICASAT AIP), Panamá

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116578PMC
May 2014
12 Reads
0.608 Impact Factor